Health

Studies show that the COVID vaccine is worth it for cancer patients

Dennis Thompson Health Day Reporter

Friday, September 24, 2021 (HealthDay News)

If you have cancer And you think it’s a coronavirus vaccination You may do a little better, don’t let your hesitation stop you from getting shots: pair Clinical trial It was found that the patient’s immune system was elevated after vaccination.

The findings were presented this week at a virtual conference of the European Medical Society. Oncology (ESMO Congress 2021).

“We have to get all the vaccinations cancer Patients, and we tell them vaccination Very active, regardless of type [cancer] Dr. Antonio Passaro, a spokesman for ESMO, HealthDay Now interview.

First COVID vaccination Excluded exams cancer Patience.So it was an open question whether the shot could protect the people receiving it. chemical treatment Or immunotherapy, he explained.

But two European exams (VOICE and CAPTURE) vaccination It certainly protects patients from COVID infections, Passaro said. lung cancer European Institute Experts Oncology In Milan, Italy.

Nearly 800 patients in the Netherlands participated in the VOICE study.It included some and some not cancer, And those who were being treated chemical treatment, Immunotherapy or a combination of the two. They received a two-dose mRNA vaccine from Moderna.

Approximately one month after the second vaccination, researchers found adequate levels of antibody in 84% of patients. chemical treatment93% of people receiving immunotherapy, 89% of people receiving combo chemical treatment/ Immunotherapy.

Passaro said the results were comparable to the high levels of antibody response seen in more than 99% of test participants who did not have them. cancer..

“The high vaccine efficacy observed across the study population, regardless of the type of anticancer treatment, constitutes a powerful and reassuring message for patients and their physicians,” Passaro said in a news release at the conference. rice field.

The study found that two doses were needed to achieve strong immunity in cancer patients. Only one in three patients with chemotherapy or chemotherapy / immunotherapy achieved a sufficient response after the first injection. This is about half of patients without cancer.

Nearly 600 cancer patients in the United Kingdom participated in the CAPTURE trial. They received either the Pfizer-BioNTech or AstraZeneca vaccine twice.

About one-third had a previous contract COVID-19 (New Coronavirus Infection), And the vaccine produced higher levels of virus-neutralizing antibodies in those patients.

For more information on the trial HealthDay Now interview:

Passaro supports the idea that these results require cancer patients and other people with weakened immunity to receive complete vaccine therapy and may require booster immunity for best results. He said.

He pointed to another clinical trial in about 230 cancer patients in Israel. Of these, less than one-third developed antibodies after the first dose of the Pfizer vaccine. Nearly 9 in 10 achieved a proper immune response when they received the second dose.

“The results confirm that our patients need a complete vaccination,” Passaro said. “All our cancer patients COVID-19 (New Coronavirus Infection), Regardless of the type of vaccine. “

Findings presented at medical conferences are considered preliminary until published in a peer-reviewed journal.

For more information

More American Cancer Society COVID vaccine and cancer..

Source: Antonio Passaro, MD, PhD, lung cancer Expert, European Institute of Oncology, Milan, Italy. ESMO Congress 2021, Virtual Conference, September 16-21, 2021

MedicalNews
Copyright © 2021 Health Day. all rights reserved.

Studies show that the COVID vaccine is worth it for cancer patients

Source link Studies show that the COVID vaccine is worth it for cancer patients

Back to top button